4D Molecular Therapeutics Inc banner

Company Overview

Business Description

Sector
Health Care
Industry
Biotechnology
Headquarters
United States of America US
Employees
196
IPO date
Dec 11, 2020

4D Molecular Therapeutics is a gene therapy company that designs and develops treatments based on adeno-associated virus, or AAV, vectors. In simple terms, it tries to deliver working genes into cells to treat diseases at the source, rather than managing symptoms. Its main work is in diseases of the eye, heart, lungs, and other tissues where a one-time genetic treatment could be valuable.

The company does not sell a broad portfolio of marketed drugs. It earns money through research-stage development, collaboration deals, and, if its programs succeed, future drug sales or licensing arrangements. Its customers today are mainly research partners, clinical trial sites, and eventually doctors, hospitals, and patients if any of its therapies win approval.

What makes 4D Molecular Therapeutics different is its focus on engineering better viral delivery systems for gene therapy. That delivery step is the hard part in this field, because the gene has to reach the right cells safely and efficiently. The company is really selling a technical platform and a pipeline of drug candidates built on that platform, which puts it in the category of high-risk, long-development biotech rather than a traditional drug maker.

4D Molecular Therapeutics Inc Investor Relations

Address
5858 Horton Street #455, Emeryville
Emeryville, California
United States of America

Business Segments

Gene therapy development

4D Molecular Therapeutics develops genetic medicines that use engineered viral vectors to deliver new DNA into cells. Its work covers designing product candidates, running laboratory and clinical studies, and advancing t...

Customers and revenue model

Management

Dr. John F. Milligan Ph.D.

Executive Chairman

Biography unavailable

Dr. David H. Kirn M.D.

Co-Founder, CEO & Director

Biography unavailable

Dr. Fariborz Kamal Ph.D.

President & COO

Biography unavailable

Dr. Noriyuki Kasahara M.D., Ph.D.

Chief Scientific Officer

Biography unavailable

Dr. Robert Y. Kim M.B.A., M.D.

Chief Medical Officer

Biography unavailable

Ms. Theresa Janke

Co-Founder & Chief of Staff

Biography unavailable

Mr. Uneek Mehra

Chief Financial & Business Officer

Biography unavailable

Dr. Scott P. Bizily J.D., Ph.D.

Chief Legal Officer & Corporate Secretary

Biography unavailable

Dr. An Song Ph.D.

Chief Development Officer

Biography unavailable

Dr. Alan H. Cohen FAAAAI, FAAP, FACAAI, FCCP, M.D.

Senior VP & Therapeutic Area Head of Pulmonology

Biography unavailable

1 / 10